Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children
Author / Expert
Julia Haehl, Beate Haeberle, Oliver Muensterer, Alexandra Hartel, Alexandra Fröba-Pohl, Chakravarthy U. Dussa, Christian M. Ziegler, Florian Obereisenbuchner, Daniel Puhr-Westerheide, Max Seidensticker, Jens Ricke, Richard Brill, Walter A. Wohlgemuth, Mar
Topic overview
Bleomycin electrosclerotherapy (BEST) is a promising treatment for slow-flow vascular malformations (SFVMs). Due to limited paediatric data, this study aimed to assess the safety, effectiveness, and patient-reported outcomes of BEST in children with SFVMs.
Comments